Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results

Click here to go back to your search results.

Rectal Cancer treatment details. Chemotherapy. Korea University Medical Center, Seoul, Korea

Survival: 5.3 months
Toxicity Grade: 4
Treatments: Chemotherapy
Country: Korea
City/State/Province: Seoul
Hospital: Korea University Medical Center
Journal: Link
Date: 3/2011

This study involved 20 patients with metastatic colorectal cancer whose disease had progressed following previous FOLFOX and FOLFIRI chemotherapy regimens.

Patients were administered the chemotherapy agent capecitabine.

The maximum reported toxicity was 1 case of grade 3-4 hand-foot syndrome (skin irritation on hands and feet). Grade 2 mucositis (inflammation of the mouth and GI tract) was also reported.

The median progression-free survival was 2.3 months and the median overall survival was 5.3 months.

Correspondence: Dr. Yeul Hong Kim

E-mail to a Friend Email Physician More Information